MIAMI, Dec. 12, 2018 (GLOBE NEWSWIRE) — Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, today announced further growth year-over-year in revenue and a record-breaking number of prescriptions filled for November 2018.
In November, the company reported a total of $1.85 million in net revenue, a 7% increase from the same month last year, and a 40% increase in prescriptions filled during the same month last year, totaling nearly 31,500 prescriptions filled. The Company’s Miami location filled a record number of prescriptions during the month of November 2018 at over 29,000 prescriptions.
“November was a big month for us. Progressive Care broke records on prescription filling and is moving forward on major initiatives,” said S. Parikh Mars, CEO of Progressive Care. “In November, we began the process of securing ownership of our first property, issuing an LOI for our next acquisition, focusing our efforts on promotion and development of our Tele-PharmCo platform, and accelerating the growth of our core business. We are confident that our high standards for patient service and value-added healthcare management offerings will lead to continued growth for many more record-breaking months to come.”
For more information about Progressive Care, please visit the company’s website.
Connect and stay in touch with us on social media:
About Progressive Care Inc.
Progressive Care Inc. (OTCQB: RXMD), through its PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long-term care facilities, and health practice risk management.
Cautionary Statement Regarding Forward-Looking Statements
Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company’s expectations about its future operating results, performance, and opportunities that involve substantial risks and uncertainties. These statements include but are not limited to statements regarding the intended terms of the offering, closing of the offering and use of any proceeds from the offering. When used herein, the words “anticipate,” “believe,” “estimate,” “upcoming,” “plan,” “target,” “intend” and “expect” and similar expressions, as they relate to Progressive Care Inc., its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company’s actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements.
Investor Relations Contact:
Armen Karapetyan, Progressive Care
Senior Advisor Business Development
Public Relations Contact:
Kathleen Gonzales, CMW Media
Web and Application Development Contact:
Marcello Jaspan, Mass Ventures Corp